In pancreatic tumour tissues, PAK1KD significantly elevated pericyte coverage, as demonstrated by a higher α-SMA/CD31 ratio (Figure 2e), whereas the NG2/CD31 ratio remained unchanged (Figure 2d). This evidence concerns the gene ACTA1 and pancreatic neoplasm.